Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.
Misonidazole has been shown to bind selectively to hypoxic cells in tissue culture and to cells which are presumed to be chronically hypoxic in EMT6 spheroids and tumors. Thus it has considerable potential as a marker of hypoxic cells in vivo. To further evaluate this potential EMT6/Ed spheroids were used to quantitate misonidazole binding under conditions which resulted in hypoxic fractions between 0 and 1. Hypoxic fractions were quantitated using radiation survival curves. A doubling of the oxygen in the gas phase to 40% was required to fully oxygenate all chronically hypoxic cells. The patterns of binding of 14C-labeled misonidazole determined by autoradiography were consistent with the regions of radiobiological hypoxia as predicted by oxygen diffusion theory. The overall uptake of 3H-labeled misonidazole by spheroids correlated well with the hypoxic fraction, although binding to aerobic cells and necrotic tissue contributed appreciably to the total label in the spheroids. It is concluded that misonidazole is an excellent marker of hypoxia in EMT6/Ed spheroids at the microscopic level, and the total amount bound per spheroid provides a potentially useful measure of the hypoxic fraction.
D000818:Animals; D001345:Autoradiography; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D000860:Hypoxia / Q000378:metabolism; D008920:Misonidazole / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000378:metabolism*; D010100:Oxygen / Q000378:metabolism*; D013997:Time Factors
D008920:Misonidazole; D010100:Oxygen